KOD

Kodiak Sciences (KOD)

About Kodiak Sciences (KOD)

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Details

Daily high

$24.43

Daily low

$21.50

Price at open

$21.69

52 Week High

$26.21

52 Week Low

$1.92

Market cap

1.2B

Dividend yield

0.00%

Volume

1.1M

Avg. volume

698,440

P/E ratio

-5.59

Kodiak Sciences News